Publications by authors named "Thomas Hucko"

Claim this Profile
A
Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS.
Masashi Fujino, Giuseppe Di Giovanni, Julie Butters Bhsc, Yu Kataoka, Thomas Hucko

Atherosclerosis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis.
Giuseppe Di Giovanni, Masashi Fujino, Yu Kataoka, Julie Butters, Thomas Hucko

Eur J Prev Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to make cardiology clinical trials more inclusive.
Faiez Zannad, Otavio Berwanger, Stefano Corda, Martin R Cowie, Habib Gamra, Thomas Hucko

Nat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
Hannes Helgason, Thjodbjorg Eiriksdottir, Magnus O Ulfarsson, Abhishek Choudhary, Sigrun H Lund, Thomas Hucko

JAMA· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes.
Stephen J Nicholls, Yu Kataoka, Steven E Nissen, Francesco Prati, Stephan Windecker, Thomas Hucko

JACC Cardiovasc Imaging· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
Stephen J Nicholls, Yu Kataoka, Steven E Nissen, Francesco Prati, Stephan Windecker, Thomas Hucko

JACC Cardiovasc Imaging· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial.
G Michael Felker, Scott D Solomon, Brian Claggett, Rafael Diaz, John J V McMurray, Thomas Hucko

JAMA Cardiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.
Stephen J Nicholls, Steven E Nissen, Francesco Prati, Stephan Windecker, Yu Kataoka, Thomas Hucko

Cardiovasc Diagn Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.
Michael J Koren, Peter H Jones, Jennifer G Robinson, David Sullivan, Leslie Cho, Thomas Hucko

Cardiol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting.
Trevor A Lentz, Lesley H Curtis, Frank W Rockhold, David Martin, Tomas L G Andersson, Thomas Hucko

Ther Innov Regul Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of myocardial tagging and feature tracking in patients with severe aortic stenosis.
Christopher Schneeweis, Tomas Lapinskas, Bernhard Schnackenburg, Alexander Berger, Thomas Hucko

J Heart Valve Dis· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of small animal cine and scar cardiac magnetic resonance imaging using a clinical 3.0 tesla system.
Robert Manka, Cosima Jahnke, Thomas Hucko, Thore Dietrich, Rolf Gebker

BMC Med Imaging· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
Thore Dietrich, Thomas Hucko, Christiane Schneemann, Marleen Neumann, Andreas Menrad

Atherosclerosis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small animal Look-Locker inversion recovery (SALLI) for simultaneous generation of cardiac T1 maps and cine and inversion recovery-prepared images at high heart rates: initial experience.
Daniel R Messroghli, Sarah Nordmeyer, Martin Buehrer, Sebastian Kozerke, Thore Dietrich, Thomas Hucko

Radiology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease.
Rolf Gebker, Cosima Jahnke, Robert Manka, Thomas Hucko, Bernhard Schnackenburg

J Cardiovasc Magn Reson· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of left ventricular hypertrophy and geometry on diagnostic accuracy of wall motion and perfusion magnetic resonance during dobutamine stress.
Rolf Gebker, Jesus G Mirelis, Cosima Jahnke, Thomas Hucko, Robert Manka

Circ Cardiovasc Imaging· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe.
Thore Dietrich, Thomas Hucko, Riad Bourayou, Cosima Jahnke, Ingo Paetsch

Int J Cardiovasc Imaging· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
Elena Kaschina, Aleksandra Grzesiak, Jun Li, Anna Foryst-Ludwig, Melanie Timm, Thomas Hucko

Circulation· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac benefits of mineralocorticoid receptor inhibition in renal failure.
Kristof Graf, Thomas Hucko, Philipp Stawowy

Hypertension· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis